top of page
Jul 8, 2025
APLS: A Closer Look at the Current Setup
APLS This stock is worth a closer look at the current enterprise value/stock price. Pros → 2 Approved early-stage drugs, → 7/28 PDUFA with solid data for next rare disease indication for EMPAVELI, → More attractive entry point for buying stock (~$2.25B MC and EV), ⚬ Valuation is now 1/2 where it was 6 months ago → ~$150M/quarter in product revenue with early products, → Early stage SiRNA asset to enhance effectiveness of SYFOVRE has exciting potential, → SYFOVRE safety issu
Jul 8, 2025


SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
Aug 7, 2023


Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
Jul 31, 2023
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH
Jul 30, 2023
Apr 3, 2023
February 2023 Big Mover™ Stocks and Movers to Watch Report
First posted 1/19/2023; last updated 3/1/23
Jan 19, 2023
Biotech PDUFAs to Watch February 2023 - TVTX, APLS, RETA
Last updated 3/1/23
Jan 10, 2023


Biopharma Daily Pulse - 08/24/22
$XBI $89.63 | +2.11% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 24, 2022


Free Biopharma Daily Pulse - 08/24/22
$XBI $89.63 | +2.11% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 24, 2022


Biopharma Mid Morning Pulse - 07/27/22
(Posted 10:05am CST) $XBI $81.35 | +0.06% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 27, 2022


Free Biopharma Mid Morning Pulse - 07/27/22
(Posted 10:05am CST) $XBI $81.35 | +0.06% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 27, 2022


Biopharma Mid Morning Pulse - 07/19/22
(Posted 9:45am CST) $XBI $82.63 | +3.62% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 19, 2022


Free Biopharma Mid Morning Pulse - 07/19/22
(Posted 9:45am CST) $XBI $82.63 | +3.62% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 19, 2022


Biopharma Mid Morning Pulse - 07/14/22
(Posted 10:30am CST) $XBI $81.43 | -2.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 14, 2022


Free Biopharma Mid Morning Pulse - 07/14/22
(Posted 10:30am CST) $XBI $81.43 | -2.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 14, 2022


Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 10, 2022


Free Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 10, 2022
EHA 2022 (European Hematology Association) - Annual Meeting
Summary: The European Hematology Association Annual 2022 Meeting is taking place from June 9-12, 2022 virtually and in-person in Vienna,...
Jun 8, 2022


Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 7, 2022
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
